Type 2 Diabetes Mellitus and Vertebral Fracture Risk.

Curr Osteoporos Rep · 2021 · PMC7935814 · PMID 33432548

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The authors reported that as compared to non-users, metformin + DPP4-inhibitor combination group had a trend towards a reduced vertebral fracture risk (HR = 0.73, P = 0.013) and showed a trend towards lower non-vertebral fracture risk compared to metformin + sulfonylurea group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.